A Persisting Dilemma for Triple Antithrombotic Therapy

A Persisting Dilemma for Triple Antithrombotic Therapy

According to European Society of Cardiology Guidelines, triple therapy (OAC, aspirin, clopidogrel) should be considered in the short term (3 to 6 months) or longer in selected patients at low bleeding risk following MI with or without PCI in patients with AF (3).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-07, Vol.64 (2), p.231-231
Hauptverfasser: Aytürk, Mehmet, MD, Sunman, Hamza, MD, Yeter, Ekrem, MD
Format: Artikel
Sprache:eng
Schlagworte:
Aspirin
Cardiology
Cardiovascular
Drug therapy
Heart attacks
Internal Medicine
Stents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:According to European Society of Cardiology Guidelines, triple therapy (OAC, aspirin, clopidogrel) should be considered in the short term (3 to 6 months) or longer in selected patients at low bleeding risk following MI with or without PCI in patients with AF (3).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2013.10.089